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CASE REPORT Open Access
Proximal 21q deletion as a result of a de
novo unbalanced t(12;21) translocation in a
patient with dysmorphic features,
hepatomegaly, thick myocardium and
delayed psychomotor development
Cathrine Jespersgaard1*, Ida N. Damgaard2, Nanna Cornelius1, Iben Bache1,3, Niels Knabe2, Maria J. Miranda2
and Zeynep Tümer1
Abstract
Background: IInterstitial 21q deletions can cause a wide spectrum of symptoms depending on the size and the
location of the deletion. It has previously been suggested that the long arm of chromosome 21 can be divided into
three regions based on the clinical severity of the patients and deletion of the region from 32.3 Mb to 37.1 Mb was
more crucial than the deletion of other regions.
Case Presentation: In this study we describe a female patient with dysmorphic features, hepatomegaly, thick
myocardium and psychomotor delay. Conventional karyotyping was initially interpreted as full monosomy 21, but
subsequent chromosome microarray analysis suggested an approximately 18 Mb partial monosomy. Re-evaluation
of the karyotype and fluorescence in situ hybridization revealed deletion of the proximal 21q11.2-q22.11 segment
and insertion of 21q22.11-qter to 12qter. The deletion of the present case overlaps with two of the proposed
regions including part of the proposed crucial region.
Conclusions: This report emphasizes the relevance of investigating suspected full monosomies with high resolution
methods and FISH in order to investigate the extent of the deletion and the presence of more complex rearrangements.
Keywords: Partial monosomy, Monosomy 21, Translocation, 21q22
Background
Full monosomy of chromosome 21 is a rare finding but
its real frequency is unknown, as some of the reported
cases, which were analysed with G-banded chromo-
somes, were subsequently shown to be partial mono-
somies when investigated with fluorescence in situ
hybridization (FISH) or other molecular techniques [1].
Full monosomy 21 has thus only been reported and con-
firmed in 14 cases [2–16]. Burgess et al. have suggested
that full monosomy 21 cases should be investigated for
cryptic unbalanced rearrangements and chromosomal
mosaicism as true monosomies may not be viable in
most cases [17]. Partial monosomy on the other hand
has been reported in more cases, but it is still a rare
finding and the patients present with a broad spectrum
of phenotypes partly correlated with the size and
localization of the deletion.
In this study, we report a chromosome rearrangement
where the proximal 21q11.2-q22.11 segment was deleted
and 21q22.11-qter was inserted to 12qter. The clinical
features of the patient, who was referred to genetic diag-
nosis at age 1 week, are described in comparison with
those of other reported cases with overlapping deletions.
Case Presentation
The patient was a female delivered by acute Caesarean
section at gestational age of 38 + 1 weeks. Labour was
medically induced because of the large size of the foetus
and shifted to Caesarean section due to imminent
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asphyxia. After birth the pH of the umbilical cord blood
was 7,16. Apgar scores were 3/1 and 7/5. Birth weight
was 4618 grams and birth height was 49 cm.
Due to respiratory distress she was treated with
NCPAP (nasal continuous positive airway pressure) for a
total of 13 days. She appeared “puffy” and with thick
subcutaneous tissue resembling diabetic foetopathy, but
with normal circulation. The mother was tested for ges-
tational diabetes twice during the pregnancy with nor-
mal results. Face of the newborn was flushing and
asymmetrical with prominence of left cheek and chin. A
subtle torticollis twisting toward the left side was no-
ticed. A sagittal swelling was present in the forehead.
She had small and low-set ears, and the right one was
crumpled. On the right hand the 3rd finger was overrid-
ing the 2nd. The left foot was inwardly rotated but re-
dressable. At birth, she had sinistra convex position,
probably due to the intrauterine posture. X-ray of thorax
revealed cardiomegaly, confirmed by echocardiography,
which also revealed cardiac myopathy with atrial septal
defect. Abdominal ultrasound revealed hepatomegaly.
She was hypotonic and had decreased motor activity.
Eye examination was normal. MRI of cerebrum revealed
hypomyelination. Hip abduction was restricted and
ultrasonography demonstrated bilateral hip dysplasia
successfully treated with Dennis-Browne brace. Metabolic
screening was normal. Initially she had problems with
sucking and feeding was supplemented by naso-gastric
tube and bottle. She was discharged from the hospital
when she was about 1-month-old and followed closely by
a team of paediatric specialists and regular physiotherapy.
Clinical examination at age 1 year showed dysmorphic
facial features including small eyes, low-set ears, and
asymmetrical chin with a deviation of the lower jaw to-
wards the left (Fig. 1c). She had levoscoliosis and syn-
chondrosis of the left elbow was suspected. Her
psychomotor development was delayed. She was able to
sit but she was still hypotonic and had tendency to use
the left extremities more. Her fine motor functions im-
proved gradually. She started to walk at the age of
22 months. Her scoliosis became less pronounced. Re-
peated eye examinations revealed slightly impaired vi-
sion of the right eye. She did not have eating problems
at this age (22 months). Language development was
a
c d
b
Fig. 1 Chromosomal microarray overview from chromosome 21 displaying the deletion at 21q11.2q22.11 (15218106-33265774)x1 (a); FISH signals
on metaphase chromosomes of the patient using the 21qter probe. One of the signals is on the normal chromosome 21 (arrow head) and the
other signal on the derivative chromosome 12 (arrow) (b); The clinical pictures of the patient at age 5 months (c) and at age 1 year (d)
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slightly delayed for the age (22 months), as she could
only make sounds without proper words. She started to
use sign language and was affiliated to a special day care.
The patient is the second child of healthy but consan-
guineous parents (the father is second nephew to the
mother). The 3-years-older sister was reported healthy
although she was a late walker.
Materials and methods
Cytogenetic analysis was carried out using Giemsa
banded metaphase chromosomes prepared from periph-
eral blood lymphocytes. Genomic DNA was prepared
from whole blood using standard procedures. Chromo-
some microarray was carried out using CytoScan HD
array and data were analysed using ChAS software (Affy-
metrix, CA, USA). FISH-analyses (Fluorescence in situ
hybridization) were carried out on metaphase chromo-
somes with commercial subtelomeric probes for 21qter,
12pter and 12qter (Vysis Inc., Abbott Laboratories SA,
IL, USA) according to manufacturer’s recommendations.
STR (short tandem repeat) markers on chromosome 21
was analysed with the Elucigene QSTR*R-21 kit as rec-
ommended by the manufacturer (Elucigene, Manchester,
United Kingdom).
Results and discussion
The initial cytogenetic analysis of the patient, carried out
by G-banded chromosomes, suggested monosomy 21,
with karyotype 45,XX,-21. Chromosomal microarray
analysis identified an approximately 18 Mb deletion at
21q11.2-q22.11 (chr21:15,218,106-33,265,774) (UCSC
Genome Browser, http://genome.ucsc.edu/, February
2009GRCh/hg19 release) (Fig. 1a). The initial karyotyp-
ing was re-evaluated revealing that the terminal 21q
was inserted to the 12qter. This was confirmed with
FISH analyses using subtelomeric probes for 21qter,
12pter and 12qter. The patient’s karyotype was hence
revised as 45,XX,der(12)t(12;21)(pter- > q24.33::q22.11- >
qter). arr[hg19] 21q11.2q22.11 (15,218,106-33,265,774)x1.
Chromosomes of the parents were investigated by cyto-
genetic analysis and FISH using the subtelomeric probes
for 21q and 12q and both had normal karyotypes. STR
analyses showed that the deletion had occurred on the pa-
ternal allele (data not shown).
Comparison of the phenotypes of the reported partial
monosomy 21 patients is difficult as in many cases the
monosomy is not pure or patients carry other rearrange-
ments including translocations, deletions or duplications
involving other chromosomes [18–22]. In the literature
there are more than 30 pure partial monosomy 21 cases
where the deletion breakpoints are investigated with
high resolution methods [21, 23–36]. Only 14 of these
patients have deletions overlapping with the deletion of
the present case (Fig. 2 and Table 1) [21, 23–29, 33].
The common features of these patients include develop-
mental delay, short stature, low birth weight, microceph-
aly, dysmorphic features, neonatal seizures, clinodactyly,
cardiac anomalies. The overlapping symptoms of the
present case and the previous reported cases are devel-
opmental delay, low set ears, scoliosis and cardiac anom-
alies. The patient reported by Roberson et al (GM06918)
has a deletion similar to that of the present case [23].
The overlapping features of these two patients are skel-
etal abnormalities, dysmorphic features and develop-
mental delay similar to the common features for all the
patients with partial monosomy in this region.
Our patient has a deletion that spans more than 60
Refseq genes including a KRTAP gene cluster comprising
16 genes (Fig. 2) and it is difficult to predict the contri-
bution of these genes to the phenotype. Based on a com-
parison of the previously reported patients (n = 11) with
partial monosomy 21, Lyle et al divided 21q into three
regions [21, 23] and the present deletion spans Region 1
and approximately 1 Mb of Region 2. The approximately
32.3 Mb region (Region 1) from the centromere to
21q11.2-q22.11 contains more than 60 genes and the
patients with deletions within this region tend to have a
severe phenotype. Region 2 (32.3 – 37.1 Mb, 21q22.11-
Fig. 2 The genomic region deleted in the present patient (black horizontal bar) and in the previously reported cases (grey bars) [21, 23–29, 33].
The Ms5Yah mouse model (horizontal striped bar) and the regions (Region 1–3, horizontal white bars) proposed by Lyle et al. [21] are also
shown. The genes shown in the figure are UCSC genes (genes that have a corresponding entry in the Protein Data Bank or the transcript has
been reviewed or validated by either the RefSeq, SwissProt or CCDS staff)
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Table 1 Summary of the clinical phenotypes of the patients presented in Fig. 2
Clinical features Present
case
Lyle
case 32
Lyle
case 33
Roberson
GM08210
Roberson
GM00137
Roberson
GM06918
Lindstrand
Pt3
Roberson
Pt3
Lindstrand
Pt2
Click Orti
LAE
Shinawi
Pt3
Lyle
case 38
Byrd Thevenon
Sex F U U F M M M F F F U F U F M
Age at latest examinationa 2 U U U U U 6 6 0.8 0.2 U U U 5 6
Development
Intellectual disability + + + + + + + + + +
Hearing loss +
Short stature + +
Low birth weight + + + + +
Delayed or no language + + +
Feeding difficulties +
Neurological
Hypotonia + + +
Hypertonia +
Craniofacial features
Facial asymmetry + +
Microcephaly +
Low anterior or posterior
hairline
+ + + + +
Frontal bossing + + +
Synophrys +
Low set ears + + + +
Large ears + +
Bulbous nose tip +
Broad or depressed nasal
bridge
+ + + + +
High or cleft palate + + + +
Broad mouth +
Micrognathia +
Downward slanting
palpebral fissures
+ + + + +
Strabismus + + + + +
Small eyes + +
Hypertelorism + +
Amblyopia +
Epicanthal folds + +
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Table 1 Summary of the clinical phenotypes of the patients presented in Fig. 2 (Continued)
Other
Gastroesophageal reflux + +
Congenital heart defect + + + + + +
Hepatomegaly +
Scoliosis + +
Distal limbs abnormalities + + + +
Clinodactoly of the fifth
finger
+
Palmar crease + + +
M male, F female, U unknown; ain years
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q22.12) contains more than 30 genes and none of the 11
patients had a deletion spanning the entire region, sug-
gesting that this region could contain genes, codeletion
of which are not tolerated [21]. The distal Region 3
(~37.1 – 38.6 Mb to 21qter, 21q22.12-q22.3) harbouring
more than 130 genes, causes a milder phenotype in
monosomic state. Patients with Region 1 and/or Region
2 deletions may present with more severe phenotypes
compared to patients with deletions of Region 3 [21, 23].
In the literature there are two patients with deletions span-
ning Region 2 [27, 28]. The patient reported by Shinawi et
al. was mosaic, where the deletion encompassing Region 2
was observed in 15 % of the cells, while the other cells had
a smaller deletion distal to Region 2 [27]. This is in line
with Lyle’s hypothesis suggesting that codeletions of two or
more genes of this region are not tolerated. A mouse model
of monosomy 21 with an approximately 9 Mb deletion cor-
responding to the human APP-RUNX1 region (distal part
of Region 1 and whole Region 2) shows developmental
delay, size and weight reduction, thrombocytopenia, motor
coordination deficiencies , and spatial learning and memory
impairments (Fig. 2) [37]. Notably, the deletion of the re-
gion influences the viability as the transmission of the allele
with the deletion is reduced, supporting Lyle’s hypothesis.
However, the patient reported by Byrd et al. does not fit this
hypothesis and description of further patients with partial
monosomy 21 is necessary to clarify the importance of Re-
gion 2 and hence the dosage effect of the genes within this
region.
Conclusion
This report emphasizes the relevance of investigating
suspected full monosomies with high resolution methods
and FISH in order to investigate the extent of the dele-
tion and the presence of more complex rearrangements.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
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review by the Editor-in-Chief of this journal.
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